Imunoterapia: um olhar na nova modalidade terapêutica do câncer / Immunotherapy: A Look at the New Cancer Therapy
DOI:
https://doi.org/10.14295/idonline.v13i47.2045Keywords:
câncer, tratamento, imunoterapiaAbstract
O câncer é um problema de saúde pública com importância crescente nas últimas décadas. Novas terapias, então, têm se mostrado necessárias para garantir maior eficácia e menor morbimortalidade relacionada ao câncer, com destaque para a imunoterapia. O objetivo deste estudo é apresentar as principais modalidades e avanços no campo da imunoterapia no tratamento oncológico, através de uma revisão de literatura. O sistema imunológico exerce papel de destaque tanto na carcinogênese, como na supressão tumoral, sendo utilizado para combater o câncer em diversas modalidades, com destaque para o tratamento prévio a cirurgia e no metastático. Neste contexto, os principais desafios são a garantia da segurança a longo prazo destas novas modalidades terapêuticas, bem como a disponibilização em larga escala para permitir a aquisição de melhores resultados no tratamento do câncer.
Downloads
References
AHN, Sarah et al. Cancer immunotherapy with T cells carrying bispecific receptors that mimic antibodies. Cancer Immunol. Res, 2019.
ALDOUS, Amanda R.; DONG, Jesse Z. Personalized neoantigen vaccines: A new approach to cancer immunotherapy. Bioorganic & medicinal chemistry, v. 26, n. 10, p. 2842-2849, 2018.
BARBOSA, Isabelle R. et al. Cancer mortality in Brazil: temporal trends and predictions for the year 2030. Medicine, v. 94, n. 16, 2015.. Acessado em 01 de agosto de 2019. doi:10.1097/MD.0000000000000746.
BARBOSA, Isabelle R. et al. Cancer mortality in Brazil: temporal trends and predictions for the year 2030. Medicine, v. 94, n. 16, 2015.. Acessado em 01 de agosto de 2019. doi:10.1097/MD.0000000000000746.
BEHRE, Ulrich et al. Clarification to Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8: 813-8. Human vaccines & immunotherapeutics, v. 8, n. 6, p. 813-818, 2012.
CHIOSSONE, Laura et al. Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more. In: Seminars in immunology. Academic Press, 2017. p. 55-63.
DUAN, Shixin et al. Natural killer group 2D receptor and its ligands in cancer immune escape. Molecular cancer, v. 18, n. 1, p. 29, 2019.
ESTEVA, Francisco J. et al. Immunotherapy and targeted therapy combinations in metastatic breast cancer. The Lancet Oncology, v. 20, n. 3, p. e175-e186, 2019.
ESTIMATIVA, I. N. C. A. Incidência de câncer no Brasil [Internet]. Instituto Nacional de Câncer José Alencar Gomes da Silva. 2017. 130 p. 2018.
GAO, Xingchun et al. Cytokine-induced killer cells as pharmacological tools for cancer immunotherapy. Frontiers in immunology, v. 8, p. 774, 2017.
GREPPI, Marco et al. Strengthening the AntiTumor NK cell function for the treatment of ovarian cancer. International journal of molecular sciences, v. 20, n. 4, p. 890, 2019.
HENDRIKS, Djoke et al. Antibody-based cancer therapy: successful agents and novel approaches. In: International review of cell and molecular biology. Academic Press, 2017. p. 289-383.
LI, Xiaoyu; BU, Xia. Progress in Vaccine Therapies for Breast Cancer. In: Translational Research in Breast Cancer. Springer, Singapore, 2017. p. 315-330.
LI, Yongfei et al. Roles of cancer/testis antigens (CTAs) in breast cancer. Cancer letters, v. 399, p. 64-73, 2017.
MAIA, Manuel Caitano; HANSEN, Aaron R. A comprehensive review of immunotherapies in prostate cancer. Critical reviews in oncology/hematology, v. 113, p. 292-303, 2017.
MENG, Yiming et al. Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application. Human vaccines & immunotherapeutics, v. 13, n. 6, p. 1379-1387, 2017.
MELIEF, Cornelis JM. Cancer: precision T-cell therapy targets tumours. Nature, v. 547, n. 7662, p. 165, 2017.
PLUMMER, Martyn et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health, v. 4, n. 9, p. e609-e616, 2016.
PULE, Martin A. et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nature medicine, v. 14, n. 11, p. 1264, 2008.
YANG, Fan et al. Adoptive cellular therapy (ACT) for cancer treatment. In: Progress in Cancer Immunotherapy. Springer, Dordrecht, 2016. p. 169-239.
YOUSEFI, Hila et al. Immunotherapy of cancers comes of age. Expert review of clinical immunology, v. 13, n. 10, p. 1001-1015, 2017.
Downloads
Published
Issue
Section
License
Os autores detêm os direitos autorais sem restrições, devendo informar a publicação inicial nesta revista, em caso de nova publicação de algum trabalho.